Recon: Novo Nordisk, Pfizer make dueling offers for obesity drugmaker Metsera; Zepbound and Mounjaro top Keytruda as world’s top-selling drug
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States